Posts

Showing posts from August, 2021

Pioglitazone for Autism and Specifically Summertime Raging and Verapamil-responsive Autism?

Image
  Adult-sized people with autism can cause property damage and much worse. I am told that summertime raging is a common problem encountered by neurologists, but it remains poorly understood and usually remains untreated. The most common worry for parents of toddlers diagnosed with severe autism is their lack of speech. By the time these children reach adulthood, the biggest worry for parents is often aggression and self-injury. Often it is the mother who faces the worst episodes of aggression, which is a really cruel turn of events. Aggression is usually not present in young children with autism, in some people it never develops, but in others it later becomes established as a learned behavior and then you are stuck with how to deal with it. One of my own therapy targets has long been to improve cognitive function; this can indeed be achieved and then you can improve important daily living skills (adaptive function). Some steps that you can take to improve cognition, and indee...

Eubiotics for GI Dysfunction and some Autism

Image
    Today’s post is about some drugs/supplements that have already been discussed in earlier posts.   Rifaximin, used in cycles, is an effective part of our reader Maja’s therapy, while Sodium Butyrate was highlighted long ago by our reader in Switzerland, Alli. I had a consultation with a gastroenterologist last week and came away with a prescription for Rifaximin, microencapsulated  Sodium Butyrate and Lactobacillus Plantarum 299v. Where we live, these are all inexpensive. Rifaximin is an antibiotic with extra benefits and costs about 7 euros (9 dollars).   A course of Rifaximin can cost $2,000 in the United States. I was pleased to read that the private equity owners of a pharmaceutical company that raised the price of a common thyroid drug by 6000% have just been fined $140 million in the UK. Advanz Pharma and former private equity owners were fined £100m by markets watchdog Perhaps some of our US readers should query the crazy price of drugs in the US...